BriefCase
Addressing Barriers to Improved Outcomes in African American Patients With Multiple Myeloma
Release Date: July 15, 2021
Expiration Date: July 14, 2022
CE/CME Credit Hours: 1.00
Pharmacology Credit Hours: 1.00
Begin »
Program Overview
Program Description
Multiple myeloma is the second most common blood cancer in the United States, and its incidence in the African American population is twice that of Whites. This activity offers learners the opportunity to engage in clinical scenarios of multiple myeloma in African American patients presented as 3 case vignettes, each featuring an expert-led video clip. Through these customized cases, learners will hone their diagnostic and therapeutic skills by making specific decisions regarding the patients' clinical care and learning why their choices are appropriate or not based on current evidence and guidelines.
Format
Video-enhanced case studies with interactive benchmarking
Learning Objectives
After completing this activity, participants should be better able to:
- Identify African American-specific clinical features of multiple myeloma and their relevance to diagnosis, risk stratification, and treatment planning
- Evaluate the appropriate use of novel agents and recommended treatment strategies in individualizing treatment of African American patients with multiple myeloma
- Identify strategies for incorporating culturally sensitive approaches to engage, educate, and advocate for African American patients with multiple myeloma
Target Audience
Oncology NPs, PAs, and nurses
Faculty
Pritesh Patel, MD
- Associate Professor of Clinical Medicine
- Division of Hematology/Oncology
- Associate Director
- Blood and Marrow Transplant Program
- University of Illinois at Chicago
- Chicago, Illinois
Details
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
NP course advisor: Amy Pierre, RN, MSN, ANP-BC, John Theurer Cancer Center, Hackensack, New Jersey
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until July 14, 2022. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Corinne Williams, PA-C, Northwestern University Feinberg School of Medicine, Chicago, Illinois
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an educational grant from AbbVie Inc., Amgen, Bristol-Myers Squibb Company, and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Patel: consulting fees/fees for non-CME/CE services: Amgen, Celgene/BMS; fees for non-CME/CE services: Janssen.
Ms Pierre: consulting fees: Celgene/BMS, Oncopeptides; salary: Flatiron Health.
Ms Williams: consulting fees/fees for non-CME/CE services: AbbVie, AstraZeneca.
None of the members of the PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: July 15, 2021
Expiration date: July 14, 2022
For Practicing Clinicians Exchange general information, contact pce@practicingclinicians.com.
© 2022 Practicing Clinicians Exchange. All Rights Reserved. 102521AJ